Molecular Biology Program

The Agnel Sfeir Lab

Research

Agnel Sfeir
Agnel Sfeir, PhD
PaineWebber Chair in Cancer Genetics

Chromosomes are the fundamental structural units of our genome. The Sfeir lab seeks to understand basic chromosome biology and how their mismanagement manifests in disease. Our research is focused on three major areas: telomere maintenance, nuclear DNA repair, and mitochondrial DNA replication and repair. A number of projects in the lab address fundamental questions related to telomere maintenance and how telomere dysfunction impacts cancer. In addition, we study an ancient yet error-prone DNA repair pathway, termed micro-homology mediated end-joining, and focus on polymerase theta, a key enzyme underlying mutagenic repair. Lastly, we investigate replication and repair of mitochondrial genomes and explore mitochondrial-nuclear crosstalk in response to mitochondrial DNA stress.

www.sfeirlab.com

Research Projects

Publications Highlights

Brambati A#, Sacco O#, Porcells A#, Heyza J, Kareh M, Schmidt JC, Sfeir A. RHINO directs MMEJ to repair DNA breaks in mitosis Science. 2023 Jul 13:eadh3694. doi: 10.1126/science.adh3694. PMID: 37440612

Tigano M, Tremblay-Belzile S, Vargas DC, Fu Y, Sfeir A* Nuclear sensing of mitochondrial DNA breaks enhances immune surveillance Nature. 2021 Feb 4:  doi: https://doi.org/10.1038/s41586-021-03269-w

Mateos-Gomez PA, Gong F, Nair N, Miller KM, Lazzerini-Denchi E, Sfeir A*. (2015) Mammalian Polymerase Theta Promotes Alternative-NHEJ and Suppresses Recombination. Nature. Feb 12;518(7538):254-7. https://doi.org/10.1038/nature14157

View All Publications

People

Agnel Sfeir

Agnel Sfeir, PhD

PaineWebber Chair in Cancer Genetics

  • The Sfeir Lab investigates pathways that ensure genome fidelity and plasticity.
  • PhD, UT Southwestern Medical Center, Texas (2006)
  • Post-Doc, The Rockefeller University, New York (2011)

Members

Ron Baik
BCMB Student
Radiation Oncology Fellow
Research Technician
BCMB Student
Bill Diplas
Radiation Oncology Fellow
Research Technician
Research Fellow
Research Fellow
Toby Lieber
Senior Research Scientist
Tri-Institutional MD-PhD Student
BCMB Student
BCMB Student
Visiting Master's Student
PBSB Student
Mike Al Kareh
Research Assistant
Raymond Barry
MSTP Student
Alessandra Brambati
Senior Research Scientist
Alejandro Friedman
Research Assistant
Yi Fu
Research Fellow
Olivia Sacco
Research Technician
Marco Tigano
Visiting Investigator

Achievements

  • Damon Runyon-Rachleff Innovator Award
  • Human Frontier Science Program Young Investigator Award
  • V-Foundation Scholar
  • Pew-Stewart Scholar for Cancer Research
  • NIH Director’s New Innovator Award
  • The David and Lucile Packard Foundation Award
  • Pershing Square Sohn Prize for Young Investigators
  • Mallinckrodt Scholar Award

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Agnel Sfeir discloses the following relationships and financial interests:

  • Repare Therapeutics
    Equity; Intellectual Property Rights; Professional Services and Activities

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures